| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 4 | |
| #2 | United States | 4 | |
| #3 | United Kingdom | 2 | |
| #4 | Hong Kong | 2 | |
| #5 | Hungary | 2 | |
| #6 | Serbia | 2 | |
| #7 | Slovenia | 2 | |
| #8 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Heterocyclic compounds | |
| #4 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Wilson Francis Xavier | 14 |
| #2 | Johnson Peter David | 13 |
| #3 | Dorgan Colin Richard | 12 |
| #4 | Vickers Richard | 11 |
| #5 | Wren Stephen Paul | 7 |
| #6 | Sudlow Lauren Jayne | 7 |
| #7 | Storer Richard | 6 |
| #8 | De Moor Olivier | 6 |
| #9 | Davis Paul James | 6 |
| #10 | Wynne Graham Michael | 6 |
| Publication | Filing date | Title |
|---|---|---|
| GB201605383D0 | Composition for the treatment of duchenne muscular dystrophy | |
| GB201605380D0 | Composition for the treatment of duchenne muscular dystrophy | |
| EP2575968A1 | Compounds for the treatment of clostridium difficile associated disease | |
| EP2907813A1 | Antibacterial pharmaceutical compositions |